Literature DB >> 15292694

CT Scan and MRI in the Differentiation of Liver Tumors.

Masatoshi Hori1, Takamichi Murakami, Tonsok Kim, Kaname Tomoda, Hironobu Nakamura.   

Abstract

Computed tomography (CT) and magnetic resonance imaging (MRI) are useful for detection and characterization of liver tumors, and widely used in clinical practice. By using dynamic CT and MRI with extracellular contrast material or MRI with liver-specific contrast material, we can investigate the morphological, hemodynamical and functional nature of focal hepatic lesions. Tumors often show characteristic findings on CT and MRI. Thus, we can correctly establish a diagnosis of liver tumors based on those findings. In this article, we describe the role of CT scan and MRI in the differentiation of liver tumors as well as presenting some typical CT and MR images. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292694     DOI: 10.1159/000078734

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  7 in total

1.  Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.

Authors:  Wen Luo; Kazushi Numata; Manabu Morimoto; Akito Nozaki; Michio Ueda; Masaaki Kondo; Satoshi Morita; Katsuaki Tanaka
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Color Doppler sonography and angioscintigraphy in hepatic Hodgkin's lymphoma.

Authors:  Mirjana V Stojković; Vera M Artiko; Irena B Radoman; Slavko J Knezević; Snezana M Lukić; Mirko D Kerkez; Nebojsa S Lekić; Andrija A Antić; Marinko M Zuvela; Vitomir I Ranković; Milorad N Petrović; Dragana P Sobić; Vladimir B Obradović
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

3.  Accuracy of frozen section in the diagnosis of liver mass lesions.

Authors:  E Rakha; S Ramaiah; A McGregor
Journal:  J Clin Pathol       Date:  2006-02-17       Impact factor: 3.411

Review 4.  Hepatic tumors: pitfall in diagnostic imaging.

Authors:  Giulia Grazzini; Diletta Cozzi; Federica Flammia; Roberta Grassi; Andrea Agostini; Maria Paola Belfiore; Alessandra Borgheresi; Maria Antonietta Mazzei; Chiara Floridi; Gianpaolo Carrafiello; Andrea Giovagnoni; Silvia Pradella; Vittorio Miele
Journal:  Acta Biomed       Date:  2020-07-13

5.  The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study.

Authors:  Liming Wang; Yunhe Liu; Weiqi Rong; Fan Wu; Weibo Yu; Kan Liu; Shengtao Lin; Yiling Zheng; Kai Zhang; Tana Siqin; Changcheng Tao; Mei Liu; Bo Chen; Qinfu Feng; Jianxiong Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

Review 6.  Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management.

Authors:  Qianwen Wang; Kangze Wu; Xuzhao Zhang; Yang Liu; Zhouyi Sun; Shumei Wei; Bo Zhang
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

7.  Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate.

Authors:  Anne Roivainen; Alexandru Naum; Heikki Nuutinen; Rauli Leino; Heimo Nurmi; Kjell Någren; Riitta Parkkola; Johanna Virtanen; Markku Kallajoki; Harry Kujari; Jari Ovaska; Peter Roberts; Marko Seppänen
Journal:  EJNMMI Res       Date:  2013-02-27       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.